All In Biotech

Free tool

FAERS Monitor: Pemetrexed

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 215179 or its brand name (Pemetrexed, Pemetrexed Disodium). Reports on generic versions are filed under their own applications.

Reports

26,175

Serious

25,665

98% of reports

Hospitalization

12,503

Death reported

4,553

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • malignant neoplasm progression2,103
  • anaemia1,501
  • nausea1,248
  • off label use1,239
  • diarrhoea1,220
  • neutropenia1,207
  • disease progression1,191
  • pancytopenia1,130
  • thrombocytopenia1,086
  • drug ineffective1,027
  • vomiting947
  • death943
  • febrile neutropenia926
  • pneumonia922
  • acute kidney injury908

Reports by year received

View as table
YearReports
200461
200550
200628
200799
2008136
2009310
2010532
2011572
2012438
2013273
2014321
2015315
2016530
2017629
20181,047
20191,407
20201,528
20212,005
20222,510
20232,947
20243,811
20253,625
20263,001

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,027,984 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
malignant neoplasm progressionSignal2,10316.816.130,796
pancytopeniaSignal1,13016.615.616,217
febrile neutropeniaSignal92611.410.78,646
disease progressionSignal1,1918.27.77,442
thrombocytopeniaSignal1,0867.97.46,478
neutropeniaSignal1,2077.26.86,408
anaemiaSignal1,5016.46.16,792
acute kidney injurySignal9084.84.52,723
pneumoniaSignal9222.32.2679
vomiting9471.61.5229
diarrhoea1,2201.51.4223
nausea1,2481.31.273
off label use1,2391.11.121
death9430.90.816
drug ineffective1,0270.60.6244

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.